Bio-Techne (TECH) Misses Q3 EPS by 8c

Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.81, $0.08 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $131 million versus the consensus estimate of $122.65 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Bio-Techne (TECH) Declares $0.08 Quarterly Dividend; 0.4% Yield
• SanDisk upgraded at JPMorgan after investor day; shares climb